|
|
|
| Changes of serum β-CTX levels in non-small cell lung cancer with bone metastasis after treated by Zoledronic acid combined with chemotherapy |
| PAN Xing-xi, YANG Wen, CHEN Yong-fa |
| Department of Oncology, Nanhai Hospital Affiliated to Southern Medical University, Foshan 528200, Guangdong, China |
|
|
|
|
Abstract Objective To investigate the clinical significance of βisomer of C-terminal telopeptide (β-CTX) in Zoledronic acid (ZOL) combined with chemotherapy for non-small cell lung cancer (NSCLC) with bone metastasis. MethodsNewly diagnosed NSCLC patients with bone metastasis (n=60) were randomised to the test group (n=30), who received ZOL combined with chemotherapy, or a control group (n=30), who received chemotherapy alone. Serum β-CTX was measured by ELISA before and after treatment in two groups. ResultsThe total effective rate was 90.00% in the treatment group were higher than that of the control group (63.33%) (P<0.05). The level of β-CTX after treatment in treatment group was lower than that before treatment (P<0.05), while in control group had no significant difference (P>0.05). ConclusionZOL administered with chemotherapy can more effectively reduce β-CTX levels for NSCLC patients with bone metastasis. Indicating that the change of β-CTX might be as a valuable index to ZOL for the treatment of NSCLC patients with bone metastasis.
|
|
|
|
|
|
| Cite this article: |
|
PAN Xing-xi,YANG Wen,CHEN Yong-fa. Changes of serum β-CTX levels in non-small cell lung cancer with bone metastasis after treated by Zoledronic acid combined with chemotherapy[J]. Electronic Journal of Metabolism and Nutrition of, 2017, 4(4): 441-444.
|
|
|
|
| URL: |
| http://www.ejmnc.org/EN/ OR http://www.ejmnc.org/EN/Y2017/V4/I4/441 |
| [1] |
YANG He-ling， JIANG Ou， LIU Yu， HE Yu， MA Cheng， HUANG Yan， MENG Fan-zhi. Progress in the treatment of stage IIIa (N2) non-small cell lung cancer[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(2): 256-260. |
| [2] |
BAI Ri-lan, CUI Jiu-wei. Clinical research progress of the systematic treatment for advanced non-small cell lung cancer in the elderly[J]. Electronic Journal of Metabolism and Nutrition of, 2019, 6(1): 125-134. |
| [3] |
LIU Jing, HU Xiao-gang, WANG Si-xiong,. Clinical effect of parenteral nutrition on patients with advanced non-small cell lung cancer after chemotherapy[J]. Electronic Journal of Metabolism and Nutrition of, 2018, 5(1): 78-83. |
| [4] |
LIU Su-yao, WANG Jun, FAN Wei-fei, MAO Yuan, Wang Lin, XU Ju-qing. Immune enteral nutrition on elderly advanced lung cancer patients with chemoherapy[J]. Electronic Journal of Metabolism and Nutrition of, 2017, 4(2): 179-184. |
|
|
|
|
